期刊文献+

复方杜仲健骨颗粒联合硫酸氨基葡萄糖治疗膝骨关节炎的临床研究 被引量:24

Clinical study on Compound Duzhong Jianggu Granules combined with glucosamine sulfate in treatment of knee osteoarthritis
原文传递
导出
摘要 目的探讨复方杜仲健骨颗粒联合硫酸氨基葡萄糖胶囊治疗膝骨关节炎的临床疗效。方法选取2017年2月-2018年2月在北京市东城区第一人民医院诊治的膝骨关节炎患者98例,根据挂号的奇偶性分为对照组(49例)和治疗组(49例)。对照组口服硫酸氨基葡萄糖胶囊,0.628 g/次,3次/d;治疗组在对照组的基础上口服复方杜仲健骨颗粒,12 g/次,3次/d。两组患者经4周治疗。观察两组患者临床疗效,同时比较治疗前后两组患者WOMAC、VAS、LKSS和ISOA评分及血清超敏C反应蛋白(hs-CRP)、软骨寡聚基质蛋白(COMP)、白细胞介素-17(IL-17)、基质金属蛋白酶-3(MMP-3)、环氧化酶-2(COX-2)水平。结果治疗后,对照组临床有效率为81.63%,显著低于治疗组的95.92%,两组比较差异有统计学意义(P<0.05)。经治疗,两组患者WOMAC评分、VAS评分、ISOA评分均明显下降(P<0.05),LKSS评分明显升高(P<0.05),且治疗组患者这些评分明显好于对照组(P<0.05)。经治疗,两组血清hs-CRP、COMP、IL-17、MMP-3、COX-2水平均显著降低(P<0.05),且治疗组患者这些血清学指标明显低于对照组(P<0.05)。结论复方杜仲健骨颗粒联合硫酸氨基葡萄糖胶囊治疗膝骨关节炎患者可改善患者膝关节功能,降低机体hs-CRP、COMP、IL-17、MMP-3、COX-2水平。 Objective To explore the clinical effect of Compound Duzhong Jianggu Granules combined with glucosamine sulfate in treatment of knee osteoarthritis. Methods Patients(98 cases) with knee osteoarthritis in Beijing Dongcheng District First People’s Hospital from February 2017 to February 2018 were divided into control(49 cases) and treatment(49 cases) groups based on registration numbers. Patients in the control group were po administered with Glucosamine Sulfate Capsules, 0.628 g/time, three times daily. Patients in the treatment group were po administered with Compound Duzhong Jianggu Granules on the basis of the control group, 12 g/time, three times daily. Patients in two groups were treated for 4 weeks. After treatment, the clinical efficacy was evaluated, and the WOMAC, VAS, LKSS and ISOA scores, and serum levels of hs-CRP, COMP, IL-17, MMP-3, and COX-2 in two groups before and after treatment were compared. Results After treatment, the clinical efficacy in the control group was 81.63%, which was significantly lower than 95.92% in the treatment group, and there were differences between two groups(P < 0.05). After treatment, the WOMAC, VAS and ISOA scores in two groups were significantly decreased(P < 0.05), but LKSS scores were significantly increased(P < 0.05), and these scores in the treatment group were significantly better than those in the control group(P < 0.05). After treatment, the serum levels of hs-CRP, COMP, IL-17, MMP-3, and COX-2 in two groups were significantly decreased(P < 0.05), and these indexes in the treatment group were significantly lower than those in the control group(P < 0.05). Conclusion Compound Duzhong Jianggu Granules combined with glucosamine sulfate in treatment of knee osteoarthritis can improve knee joint function, and reduce the serum hs-CRP, COMP, IL-17, MMP-3, COX-2 levels.
作者 刘磊 张舒 周悦悦 LIU Lei;ZHANG Shu;ZHOU Yue-yue(Department of Orthopaedics,Beijing Dongcheng District First People's Hospital,Beijing 100075,China)
出处 《现代药物与临床》 CAS 2019年第11期3343-3346,共4页 Drugs & Clinic
关键词 复方杜仲健骨颗粒 硫酸氨基葡萄糖胶囊 膝骨关节炎 软骨寡聚基质蛋白 基质金属蛋白酶-3 环氧化酶-2 Compound Duzhong Jianggu Granules Glucosamine Sulfate Capsules Knee osteoarthritis COMP MMP-3 COX-2
  • 相关文献

参考文献10

二级参考文献133

  • 1Hayami T,Pickarski M,Zhuo Y,et al.Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transaction and meniscectomized models of osteoarthritis[J].Bone,2006,38(2):234-243.
  • 2Di Battista JA,Fahm i H,He Y,et al.Differential regulation of interleukin-1 beta-induced cyclooxygenase-2 gene expression by nimesulide in human synovial fibroblasts[J].Clin Exp Rheumatol,2001,19 (1):S325.
  • 3Boer TN,Huisman AM,Polak AA,et al.The chondroprotective effect of selective COX-2 inhibition in osteoarthritis:ex vivo evaluation of human cartilage tissue after in vivotreatment.Osteoarthritis Cartilage.2009,17(4):482-8.
  • 4Brittberg M,Peterson L,Sjogren Jansson E,et al.Articular cartilage engineering with autologous chondrocyte transplantation:a review of recent developments[J].Bone Joint Surg(Am),2003,85Suppl 3:109.
  • 5Sarzi-Puttini P,Cimmino MA,Scarpa R,et al. Osteoarthritis:an overview of the disease and its treatment strategies[J]. Semin Arthritis Rheum, 2005,35 (1) :1 - 10.
  • 6Brief AA, Mauler SG, Di Cesare PE. Use of glucosamine and chondroitin sulfate in the management of osteoarthritis[J]. J Am Aead Orthop Surg,2001,9(2) :71 - 78.
  • 7Hoffer LJ, Kaplan LN, Hamadeh MJ, et al. Sulfate could mediate the therapeutic effect of glucosamine sulfate[J]. Metabolism,2001,50(7) : 767 -770.
  • 8Piperno M, Reboul P, Hellio - Le - Graven'and MP, et al. Glucosamine sulfate modulates dysregulated activities of human osteoarthritis chondrocytes in vitro [ J ]. Osteoarthritis Cartilage, 2000,8 (3) : 207 - 212.
  • 9Gouze JN, Bordji K, Gulberti S,et al. Interleukin - lbeta down - regulates the expression of glucuronosyhransferase I,a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin- lbeta-mediated effects in rat chondrocytes[J]. Arthritis Rheum, 2001,44(2): 351 - 360.
  • 10McCarty MF, Russell AL, Seed MP. Sulfated glycosarninoglycans and glucosamine may synergize in promoting synovial hyaluronic acid synthesis [ J ]. Med Hypotheses, 2000,54 (5) : 798 - 802.

共引文献3723

同被引文献304

引证文献24

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部